WallStreetZenWallStreetZen

NASDAQ: IMMX
Immix Biopharma Inc Stock

$3.14+0.52 (+19.85%)
Updated Feb 3, 2023
IMMX Price
$3.14
Fair Value Price
N/A
Market Cap
$43.73M
52 Week Low
$0.68
52 Week High
$5.37
P/E
-0.48x
P/B
2.61x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$27.19M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.04
Operating Cash Flow
-$5M
Beta
0.8
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

IMMX Overview

Immix Biopharma, Inc. is developing tissue-specific therapeutics to treat cancer and inflammatory diseases. The company's pipeline includes IMX-110, in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors, IMX-111, a tissue-specific biologic for the treatment of colorectal cancers, and IMX-120, a tissue-specific biologic for the treatment of ulcerative colitis and severe Crohn's disease. Immix Biopharma was incorporated in 2012 and is headquartered in Los Angeles, CA.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IMMX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IMMX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IMMX is good value based on its book value relative to its share price (2.61x), compared to the US Biotechnology industry average (5.11x)
P/B vs Industry Valuation
IMMX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more IMMX due diligence checks available for Premium users.

Be the first to know about important IMMX news, forecast changes, insider trades & much more!

IMMX News

Valuation

IMMX fair value

Fair Value of IMMX stock based on Discounted Cash Flow (DCF)
Price
$3.14
Fair Value
$3.41
Undervalued by
8.05%
IMMX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

IMMX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.48x
Industry
10.7x
Market
15.09x

IMMX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.61x
Industry
5.11x
IMMX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

IMMX's financial health

Profit margin

Revenue
$0.0
Net Income
-$1.5M
Profit Margin
0%
IMMX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$17.4M
Liabilities
$646.5k
Debt to equity
0.04
IMMX's short-term assets ($17.39M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IMMX's short-term assets ($17.39M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IMMX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.5M
Investing
$0.0
Financing
$0.0
IMMX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

IMMX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
IMMX$43.73M+20.08%-0.48x2.61x
TCRX$43.82M+0.55%-1.14x0.38x
MEIP$43.98M-0.90%-0.80x1.18x
MNPR$44.22M+2.08%-4.25x3.54x
PMN$42.54M-3.90%N/A58.30x

Immix Biopharma Stock FAQ

What is Immix Biopharma's quote symbol?

NASDAQ: IMMX) Immix Biopharma trades on the NASDAQ under the ticker symbol IMMX. Immix Biopharma stock quotes can also be displayed as NASDAQ: IMMX.

If you're new to stock investing, here's how to buy Immix Biopharma stock.

What is the 52 week high and low for Immix Biopharma (NASDAQ: IMMX)?

(NASDAQ: IMMX) Immix Biopharma's 52-week high was $5.37, and its 52-week low was $0.68. It is currently -41.53% from its 52-week high and 361.76% from its 52-week low.

How much is Immix Biopharma stock worth today?

(NASDAQ: IMMX) Immix Biopharma currently has 13,927,067 outstanding shares. With Immix Biopharma stock trading at $3.14 per share, the total value of Immix Biopharma stock (market capitalization) is $43.73M.

Immix Biopharma stock was originally listed at a price of $3.67 in Dec 16, 2021. If you had invested in Immix Biopharma stock at $3.67, your return over the last 1 years would have been -14.44%, for an annualized return of -14.44% (not including any dividends or dividend reinvestments).

How much is Immix Biopharma's stock price per share?

(NASDAQ: IMMX) Immix Biopharma stock price per share is $3.14 today (as of Feb 3, 2023).

What is Immix Biopharma's Market Cap?

(NASDAQ: IMMX) Immix Biopharma's market cap is $43.73M, as of Feb 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Immix Biopharma's market cap is calculated by multiplying IMMX's current stock price of $3.14 by IMMX's total outstanding shares of 13,927,067.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.